We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > News
Cannabis & Psychedelics News

This New Study Will Test If an Endocannabinoid Can Treat Alzheimer’s

Researchers from the University of Texas Health Science Center, San Antonio have begun a study to see if the body’s own cannabinoids can help treat Alzheimer’s disease.

Read More

Nevada Consumers Advised to Avoid Cannabis Flower That Tested Positive For Aspergillus

Cannabis consumers in Nevada have been advised by the state’s cannabis regulator to avoid or “take caution” when consuming the “Dancing Monkey” product.

Read More

Oklahoma Has 32 Times More Medical Cannabis Than It Needs, Study Finds

Given this vast oversupply of cannabis, the study says it is likely that, to offload their products, many licensed medical cannabis businesses are supplying the state’s illicit market.

Read More

Feeling High May Be an Unavoidable Aspect of Medical Cannabis, Study Suggests

Medical cannabis patients who reported getting high are more likely to feel greater symptom relief, according to a new study.

Read More

Cannabis Oil Provides ‘Moderate’ Treatment For Tourette’s, Trial Finds

Cannabis oil is just as effect at reducing the number of tics a person with Tourette’s syndrome experiences as many existing treatments, according to a new study.

Read More

‘Many’ Cannabis Samples Are Adulterated in Colorado, Says Regulator

The cannabis regulator in Colorado has identified ‘many examples’ of adulterated test batches, according to a recent notice.

Read More

RAW Rolling Paper Producer Awarded a Further $446,000 in Lawsuit With Republic Tobacco

The manufacturer of RAW Organic Hemp rolling papers – a popular brand among cannabis consumers – has reportedly resolved its seven-year court battle with Republic Tobacco (also known as Republic Brands).

Read More

New Drug Can Treat Cannabis Use Disorder, Researchers Say

Encouraged by these findings, the researchers say that they are currently operating a longer three-month study of the drugs in patients seeking treatment for CUD.

Read More

 
Advertisement